首页|期刊导航|中国中药杂志|疏风解毒胶囊对甲型H1N1流感病毒肺炎小鼠恢复期肺损伤修复及T细胞亚群比例的影响

疏风解毒胶囊对甲型H1N1流感病毒肺炎小鼠恢复期肺损伤修复及T细胞亚群比例的影响OA

Effects of Shufeng Jiedu Capsules on lung injury repair and T cell subset proportions during recovery period in mice with influenza A H1N1 pneumonia

中文摘要英文摘要

该研究旨在探讨疏风解毒胶囊(SFJD)对甲型 H1N1 流感病毒感染小鼠恢复期药效学、辅助性 T 细胞(Th)比例、CD8+T 细胞免疫记忆形成的影响.采用甲型流感病毒 A/PR/8/34(PR8)株滴鼻感染小鼠,建立非致死性肺炎小鼠模型,随机分为感染后第 7、10、13 天时间点(7、10、13 dpi)组,每组 30 只,并将各时间点小鼠随机分为正常组,PR8 模型组,阳性药(磷酸奥司他韦)组(0.027 5 g·kg-1·d-1),SFJD 高、低剂量组(2.558、1.279 g·kg-1·d-1),每组 6 只.0 dpi 至取材当天(7、10、13 dpi)灌胃给药,正常组和 PR8 模型组给予等体积去离子水.于以上时间点对各组小鼠取材,分别称量各组小鼠肺质量和体质量,计算肺指数;于 10 dpi,使用 Micro-CT 观察小鼠肺部状态影像;采用 qRT-PCR 检测各组小鼠肺组织病毒载量;采用流式细胞术检测 3 个时间点外周血和肺组织CD4+T 和CD8+T 细胞比例;经实验确定10 dpi 进行后续研究,采用流式细胞术检测肺组织中Th 细胞亚群 Th1 和 Th2 比例,以及 CD8+T 细胞亚群初始 CD8+T 细胞、中央记忆 CD8+T 细胞、效应 CD8+T 细胞比例和记忆前体效应CD8+T 细胞比例.SFJD 可升高小鼠体质量,降低3 个时间点肺指数;改善10 dpi 小鼠肺部形态,降低肺部病毒载量;升高7 dpi 外周血 CD8+T 细胞比例;升高肺组织 7 dpi 的 CD4+T 细胞比例,降低 7、10、13 dpi 的 CD8+T 比例.通过检测 3 个时间点肺指数、外周血和肺组织 CD4+T 和 CD8+T 细胞比例,确定于10 dpi 肺组织中研究 SFJD 对 T 细胞亚群的影响.SFJD 可通过抑制 Th1、效应 CD8+T 细胞分化,促进初始 CD8+T 细胞、中央记忆 CD8+T 细胞、记忆前体效应 CD8+T 细胞生成,阻止炎症持续,促进免疫记忆形成,从而促进甲型 H1N1 流感病毒性肺炎轻症感染的恢复.

This study investigated the effects of Shufeng Jiedu Capsules(SFJD)on pharmacodynamics,T helper cell(Th)proportions,and CD8+T-cell immune memory formation during the recovery phase in mice infected with influenza A H1N1 virus.A non-lethal pneumonia mouse model was established by intranasal inoculation with influenza A virus A/PR/8/34(PR8)strain.Mice were randomly divided into three time-point groups:7,10,and 13 days post-infection(dpi),with 30 mice in each group.At each time point,mice were further randomly divided into a normal group,PR8 model group,positive drug group(oseltamivir phosphate,0.027 5 g·kg-1·d-1),and high-and low-dose SFJD groups(2.558 and 1.279 g·kg-1·d-1),with six mice in each subgroup.From 0 dpi until the day of sample collection(7,10,or 13 dpi),mice were administered the corresponding drugs by gavage,while the normal and PR8 model groups received equal volumes of deionized water.At the indicated time points,mice were sacrificed for sample collection.Lung and body weights were measured to calculate the lung index.At 10 dpi,Micro-CT was used to observe lung imaging changes.Viral load in lung tissue was detected by qRT-PCR.Flow cytometry was used to determine the proportions of CD4+T cells and CD8+T cells in peripheral blood and lung tissue at the three time points.Based on preliminary experimental results,10 dpi was selected for further analysis of T-cell subsets in lung tissue by flow cytometry,including Th1 and Th2,as well as naive CD8+T cells,central memory CD8+T cells,effector CD8+T cells,and memory precursor effector CD8+T cells.The results showed that SFJD increased body weight and reduced lung index at all three time points,improved lung morphology at 10 dpi,and reduced viral load in lung tissue.SFJD also increased the proportion of CD8+T cells in peripheral blood at 7 dpi,increased the proportion of CD4+T cells in lung tissue at 7 dpi,and reduced the proportion of CD8+T cells in lung tissue at 7,10,and 13 dpi.Based on analyses of lung index and the proportions of CD4+and CD8+T cells in peripheral blood and lung tissue at the three time points,10 dpi was selected to investigate the effects of SFJD on T-cell subsets in lung tissue.SFJD promoted recovery from mild influenza A H1N1 viral pneumonia by inhibiting differentiation of Th1 cells and effector CD8+T cells,while promoting the generation of naive CD8+T cells,central memory CD8+T cells,and memory precursor effector CD8+T cells,thereby preventing persistent inflammation and facilitating immune memory formation.

李欣颖;包蕾;李舒冉;赵荣华;孙静;谢丹;郭姗姗;崔晓兰;耿子涵

中国中医科学院 中药研究所,北京 100700中国中医科学院 中药研究所,北京 100700中国中医科学院 中药研究所,北京 100700中国中医科学院 中药研究所,北京 100700中国中医科学院 中药研究所,北京 100700中国中医科学院 中药研究所,北京 100700中国中医科学院 中药研究所,北京 100700中国中医科学院 中药研究所,北京 100700中国中医科学院 中药研究所,北京 100700

甲型H1N1流感病毒病毒性肺炎疏风解毒胶囊细胞免疫T细胞亚群

influenza A virus H1N1viral pneumoniaShufeng Jiedu Capsulescellular immunityT cell subsets

《中国中药杂志》 2026 (18)

5198-5207,10

国家自然科学基金项目(82305078)中国中医科学院科技创新工程项目(CI2021A04620)中医疫病防治药效评价创新体系构建及新药研发项目(ZXKT25038)

10.19540/j.cnki.cjcmm.20260523.801

评论